Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study).

Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML.

Am J Cardiol. 2005 Apr 1;95(7):869-71.

PMID:
15781019
2.

Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.

Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, Morrow J, Ridker P, Rifai N, Mietus-Snyder M.

Int J Clin Pharmacol Ther. 2004 Dec;42(12):672-9.

PMID:
15624283
3.

Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.

Superko HR, Garrett BC, King SB 3rd, Momary KM, Chronos NA, Wood PD.

Am J Cardiol. 2009 Feb 1;103(3):387-92. doi: 10.1016/j.amjcard.2008.09.103. Epub 2008 Nov 27.

PMID:
19166694
4.

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

Kelley DS, Siegel D, Vemuri M, Mackey BE.

Am J Clin Nutr. 2007 Aug;86(2):324-33.

5.

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.

Calabresi L, Donati D, Pazzucconi F, Sirtori CR, Franceschini G.

Atherosclerosis. 2000 Feb;148(2):387-96.

PMID:
10657575
6.

Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.

Mostad IL, Bjerve KS, Lydersen S, Grill V.

Eur J Clin Nutr. 2008 Mar;62(3):419-29. Epub 2007 Feb 28.

PMID:
17327864
7.

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN; COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.

Clin Ther. 2007 Jul;29(7):1354-67.

PMID:
17825687
8.
9.

Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol.

Maki KC, Van Elswyk ME, McCarthy D, Hess SP, Veith PE, Bell M, Subbaiah P, Davidson MH.

J Am Coll Nutr. 2005 Jun;24(3):189-99.

PMID:
15930485
10.

Long-chain polyunsaturated fat supplementation in children with low docosahexaenoic acid intakes alters immune phenotypes compared with placebo.

Mazurak VC, Lien V, Field CJ, Goruk SD, Pramuk K, Clandinin MT.

J Pediatr Gastroenterol Nutr. 2008 May;46(5):570-9. doi: 10.1097/MPG.0b013e31816a62eb.

PMID:
18493214
11.

Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.

Meyer BJ, Hammervold T, Rustan AC, Howe PR.

Lipids. 2007 Mar;42(2):109-15. Epub 2007 Feb 8.

PMID:
17393216
12.
13.
14.

Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial.

Agostoni C, Zuccotti GV, Radaelli G, Besana R, Podestà A, Sterpa A, Rottoli A, Riva E, Giovannini M.

Am J Clin Nutr. 2009 Jan;89(1):64-70. doi: 10.3945/ajcn.2008.26590. Epub 2008 Dec 3.

15.
16.

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.

Nobili V, Bedogni G, Alisi A, Pietrobattista A, Risé P, Galli C, Agostoni C.

Arch Dis Child. 2011 Apr;96(4):350-3. doi: 10.1136/adc.2010.192401. Epub 2011 Jan 12.

PMID:
21233083
17.

Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study.

Ryan AS, Nelson EB.

Clin Pediatr (Phila). 2008 May;47(4):355-62. doi: 10.1177/0009922807311730. Epub 2008 Jan 7.

PMID:
18180340
18.

Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.

Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, Tanouchi M, Watanabe S, Hamazaki T, Terasawa K, Yazawa K.

Nutrition. 2005 Jun;21(6):705-10.

PMID:
15925295
19.

Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.

Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.

Am J Cardiol. 2005 Nov 1;96(9):1266-72. Epub 2005 Sep 8.

PMID:
16253595
20.

Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women.

Allen JK, Becker DM, Kwiterovich PO, Lindenstruth KA, Curtis C.

Menopause. 2007 Jan-Feb;14(1):106-14.

PMID:
17019375
Items per page

Supplemental Content

Write to the Help Desk